A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
A Phase 1b Dose Escalation Study of the Safety and Pharmacodynamics of Brontictuzumab in
Combination with Chemotherapy for Subjects with Previously Treated Metastatic Colorectal
Cancer.